首页> 外文OA文献 >ATCT-16CODEL (ALLIANCE-N0577; EORTC-26081/2208; NRG-1071; NCIC-CEC-2): PHASE III RANDOMIZED STUDY OF RT VS. RT + TMZ VS. TMZ FOR NEWLY DIAGNOSED 1p/19q-CODELETED ANAPLASTIC GLIOMA. ANALYSIS OF PATIENTS TREATED ON THE ORIGINAL PROTOCOL DESIGN

【2h】

ATCT-16CODEL (ALLIANCE-N0577; EORTC-26081/2208; NRG-1071; NCIC-CEC-2): PHASE III RANDOMIZED STUDY OF RT VS. RT + TMZ VS. TMZ FOR NEWLY DIAGNOSED 1p/19q-CODELETED ANAPLASTIC GLIOMA. ANALYSIS OF PATIENTS TREATED ON THE ORIGINAL PROTOCOL DESIGN

机译：ATCT-16CODEL（ALLIANCE-N0577; EORTC-26081/2208; NRG-1071; NCIC-CEC-2）：第III期RT与RT VS的随机研究。 RT + TMZ与TMZ用于新诊断的1p / 19q-codeleted Anploplastic glioma。原始协议设计患者分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Kurt Jaeckle; Michael Vogelbaum; Karla Ballman; Caterina Giannini; Kenneth Aldape; Jane Cerhan; Jeffrey Wefel; Donald Nordstrom; Robert Jenkins; Martin Klein; Jeffrey Raizer; Martin van den Bent; Wolfgang Wick; Patrick Flynn; Frederick Dhermain; Gregory Cairncross; Paul Brown;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. CODEL: phase Ⅲ study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design [J] . Jaeckle Kurt A., Ballman Karla V, van den Bent Martin, Neuro-Oncology . 2021,第3期

机译：Codel：NOR，RT + TMZ或TMZ的Ⅲ期研究，用于新诊断的1P / 19Q Codeleted Oligodendroglioma。初始研究设计分析
2. 311 Temozolomide (TMZ) combined with radiotherapy (RT) versus radiotherapy (RT) alone in newly diagnosed glioblastoma multiforme (GBM): A randomized phase III study [J] . H.Athanassiou, M.Synodinou, E.Maragoudakis, European Journal of Cancer Supplements . 2003,第5期

机译：311替莫唑胺（TMZ）联合放疗（RT）与单独放疗（RT）在新诊断的多形性胶质母细胞瘤（GBM）中的应用：一项随机III期研究
3. Elevated MGMT Gene Expression is Independently Associated with Worse Overall Survival in NRG Oncology/RTOG 9813: A Phase III Study of Radiation Therapy (RT) and Temozolomide (TMZ) Versus RT and Nitrosourea (NU) in Anaplastic Grade III Glioma [J] . Fleming J., McElroy J., Bell E. H., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：升高的MGMT基因表达与NRG肿瘤学/ RTOG 9813中的总体存活较差：AII研究的放射治疗（RT）和替莫唑胺（TMZ）与RT和亚硝基（NU）在血管基级胶质瘤
4. ATCT-16CODEL (ALLIANCE-N0577; EORTC-26081/2208; NRG-1071; NCIC-CEC-2): PHASE III RANDOMIZED STUDY OF RT VS. RT + TMZ VS. TMZ FOR NEWLY DIAGNOSED 1p/19q-CODELETED ANAPLASTIC GLIOMA. ANALYSIS OF PATIENTS TREATED ON THE ORIGINAL PROTOCOL DESIGN [O] . Kurt Jaeckle, Michael Vogelbaum, Karla Ballman, 2015

机译：ATCT-16CODEL（ALLIANCE-N0577; EORTC-26081 / 2208; NRG-1071; NCIC-CEC-2）：RT VS的第三阶段随机研究。 RT + TMZVS。适用于新诊断的1p / 19q编码的无胶质胶质瘤的TMZ。原始协议设计中治疗的患者的分析
5. ATNT-12PHASE I, TWO-STAGE, OPEN-LABEL, DOSE-ESCALATION STUDY OF BUPARLISIB (BKM120) IN COMBINATION WITH ADJUVANT TEMOZOLOMIDE (TMZ) AND WITH CONCOMITANT RADIATION THERAPY (RT) AND TMZ IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM) [O] . Jordi Rodon, Mark Rosenthal, Warren Mason, 2015

机译：atnt-12phase i，两阶段，开放标签，对Buptlisib（bkm120）的升级与佐剂替替莫唑胺（TMZ）和新诊断的胶质母细胞瘤（GBM）的伴随的放射治疗（RT）和TMZ组合

ATCT-16CODEL (ALLIANCE-N0577; EORTC-26081/2208; NRG-1071; NCIC-CEC-2): PHASE III RANDOMIZED STUDY OF RT VS. RT + TMZ VS. TMZ FOR NEWLY DIAGNOSED 1p/19q-CODELETED ANAPLASTIC GLIOMA. ANALYSIS OF PATIENTS TREATED ON THE ORIGINAL PROTOCOL DESIGN

著录项

相似文献

相关主题

期刊订阅